Quantification of alcohol intake in patients with steatotic liver disease and excessive alcohol intake

An accurate quantification of alcohol intake is crucial in the clinical phenotyping of patients with steatotic liver disease and when designing clinical trials. This study found self-reported abstinence to be reliable but phosphatidylethanol was a more accurate prognostic biomarker of hepatic decompensation and death in a clinical trial setting. Findings may inform the design of future trials in patients with steatotic liver disease.

Authors

Institutions

Publication Details

Journal
JHEP Reports
Published
2024-09-02
DOI
https://doi.org/10.1016/j.jhepr.2024.101200
Citations
21
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
8.12

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Quantification of alcohol intake in patients with steatotic liver disease and excessive alcohol intake

Camilla Dalby Hansen, Gitte Hedegaard Jensen, Katrine Holtz Thorhauge, Peter Andersen et al.
21 citations
JHEP Reports
Liver Disease Diagnosis and Treatment
8.12
article

Quantification of alcohol intake in patients with steatotic liver disease and excessive alcohol intake

Camilla Dalby Hansen, Gitte Hedegaard Jensen, Katrine Holtz Thorhauge, Peter Andersen, K. Bech, Emmanuel Tsochatzis, Katrine Prier Lindvig, Jonel Trebicka, Mads Israelsen, Ida Falk Villesen, Stine Johansen, Aleksander Krag, Johanne Kragh Hansen, Nikolaj Torp, Maja Thiele, M Bergmann, Sönke Detlefsen, Torben Hansen, Emil Deleuran Hansen
article en
21 citations

Abstract

An accurate quantification of alcohol intake is crucial in the clinical phenotyping of patients with steatotic liver disease and when designing clinical trials. This study found self-reported abstinence to be reliable but phosphatidylethanol was a more accurate prognostic biomarker of hepatic decompensation and death in a clinical trial setting. Findings may inform the design of future trials in patients with steatotic liver disease.

JHEP ReportsVol. 7(1)
University of Copenhagen (DK), University of Southern Denmark (DK), Novo Nordisk Foundation (DK), The Royal Free Hospital (GB), Odense University Hospital (DK), European Foundation for the Study of Chronic Liver Failure (ES), University Hospital Münster (DE), Region of Southern Denmark (DK), University College London (GB)
Novo Nordisk Fonden, HORIZON EUROPE Framework Programme
Good health and well-being
Openalex Percentile: Top 2%
Liver Disease Diagnosis and Treatment
8.12
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.